Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Palizhati Rehati
Observed name:
P. Rehati
Institutions:
Shanghai Medical College of Fudan University,
Fudan University
Observed institutions:
Shanghai Medical College of Fudan University,
Capital Medical University,
Fudan University,
Shanghai Public Health Clinical Center
ORCID:
0000-0001-9545-1071
Observed ORCID:
0000-0001-9545-1071
OpenAlex ID:
A5014599416
The potential toxicity of microplastics on human health
2023
·
Bosen Zhao
, Palizhati Rehati
, et al.
·
The Science of The Total Environment
·
415
COVID-19 Vaccine Hesitancy among Adolescents: Cross-Sectional School Survey in Four Chinese Cities Prior to Vaccine Availability
2022
·
Palizhati Rehati
, Nubiya Amaerjiang
, et al.
·
Vaccines
·
37
PDF
A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses
2024
·
Yingdan Wang
, Aihua Hao
, et al.
·
Nature Communications
·
11
A broadly neutralizing antibody inhibits SARS-CoV-2 variants through a novel mechanism of disrupting spike trimer integrity
2023
·
Yunping Ma
, Qiyu Mao
, et al.
·
Cell Research
·
6
PDF
Synergistic impact of macrolide resistance and H3N2 infection on M. pneumoniae outbreak in children
2025
·
Jiali Chen
, Yingdan Wang
, et al.
·
Microbiology Spectrum
·
3
A potent and broad CD4 binding site neutralizing antibody with strong ADCC activity from a Chinese HIV-1 elite neutralizer
2025
·
Yingdan Wang
, Ping Ji
, et al.
·
Cell Discovery
·
2
PDF
Structure-guided bispecific antibody engineering confers broad protection against KP.3.1.1 and sarbecoviruses
2025
·
Yunping Ma
, Qianying Liu
, et al.
·
iScience
·
1
Show more works
View as search
Works count:
8
Citation count:
475
H-index:
4
I10-index:
3
Year
Topic
Type